Cue Biopharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-14. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.
Showing 25 of 43 people.
| Name | Role | Location |
|---|---|---|
| DANIEL BAKER | Related Person | Boston, MA |
| Jill M. Broadfoot | Related Person | Boston, MA |
| Pamela D. Garzone | Related Person | Boston, MA |
| Peter Kiener | Related Person | St. Louis, MO |
| Shao-Lee Lin | Related Person | Boston, MA |
| Frank Morich | Related Person | Boston, MA |
| Colin Sandercock | Related Person | Boston, MA |
| Pasha Sarraf | Related Person | Boston, MA |
| Patrick Verheyen | Related Person | Boston, MA |
| Peter Kiener | Director | St. Louis, MO |
| Anthony DiGiandomenico | Director | Tulsa, OK |
| Christopher Marlett | Director | Addison, TX |
| Barry Simon | Director | Santa Monica, CA |
| Dominic Borie | Related Person | Boston, MA |
| DANIEL CAMARDO | Related Person | Boston, MA |
| Amy Wang | Director | Palo Alto, CA |
| Amy Wang | Executive Officer | Palo Alto, CA |
| Tamar G Howson | Director | Boston, MA |
| Daniel R Passeri | Director | Boston, MA |
| Daniel R Passeri | Executive Officer | Boston, MA |
| Aaron G Fletcher | Director | Boston, MA |
| Peter A Kiener | Director | Boston, MA |
| Kerri-Ann R Millar | Executive Officer | Boston, MA |
| Anish R Suri | Executive Officer | Boston, MA |
| Frank G Morich | Director | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-07-22 | D | $50.0M | $50.0M |
| 2022-11-21 | D | $30.0M | $30.0M |
| 2016-12-30 | D/A | $16.4M | $16.4M |
| 2016-12-22 | D | $20.0M | $20.0M |
| 2015-06-19 | D | $10.0M | $10.0M |
| 2015-06-19 | D | $1.0M | — |